Seguridad y eficacia de la monoterapia con ticagrelor en pacientes con síndromes coronarios agudos sometidos a intervención coronaria percutánea: un metanálisis de los datos de pacientes individuales de los ensayos aleatorizados TWILIGHT y TICO
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La monoterapia con ticagrelor después de 3 meses de tratamiento antiplaquetario dual reduce significativamente el sangrado mayor en pacientes con síndrome coronario agudo (SAA) sometidos a intervención coronaria percutánea (ICP). Esta estrategia mantiene tasas similares de eventos isquémicos en comparación con el tratamiento dual continuado.
Área De La Ciencia
- Cardiología
- Farmacología
- Ensayos clínicos
Sus Antecedentes
- El tratamiento antiplaquetario dual (DAPT) con aspirina y un inhibidor de P2Y12 es estándar para los pacientes con síndrome coronario agudo (SAA) después de la intervención coronaria percutánea (ICP).
- Se está explorando la monoterapia con ticagrelor después de la TDAP inicial como estrategia para reducir los eventos hemorrágicos.
Conclusiones
- La interrupción de la aspirina después de 3 meses de DAPT y el cambio a la monoterapia con ticagrelor es una estrategia segura y efectiva.
- Este enfoque reduce el riesgo de hemorragia mayor sin aumentar el riesgo isquémico en pacientes con SCA después de la ICP.
- La monoterapia con ticagrelor representa una alternativa viable para reducir el sangrado en esta población de pacientes.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...